Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Seelos Therapeutics, Inc. - Common Stock
(NQ:
SEEL
)
1.280
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seelos Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
6 Largest Psychedelic Stocks Showing Strength; Up 11.5% YTD
↗
February 17, 2023
A look at the performance of the six largest psychedelic stocks by market capitalization.
Via
Talk Markets
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
↗
February 17, 2023
Via
Benzinga
Cybin, Compass Pathways Among Top Psychedelic Movers Of Today
↗
February 16, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 15, 2023
↗
February 15, 2023
Via
Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
↗
February 14, 2023
Via
Benzinga
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
↗
February 13, 2023
Via
Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
↗
February 13, 2023
Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More
Via
Benzinga
Psychedelics Are Proving Their Mettle Against Trauma, Anxiety
February 13, 2023
Via
Investor Brand Network
Topics
Cannabis
"Multi-Bagger" Portfolio Update
↗
February 12, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say
Via
Talk Markets
Major Psychedelic Compound-Based Stocks UP 13% YTD
↗
February 11, 2023
We track the performance of the 6 largest companies researching the treatment of mental illnesses based on the use of one or more of 10 different psychedelic compound-based substances.
Via
Talk Markets
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
February 10, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
↗
February 09, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
↗
February 08, 2023
Via
Benzinga
Seelos Dosing Participants In Psychedelics Study, Seeks Japanese Subjects In Major Depression Therapy
↗
February 07, 2023
Clinical-stage biopharma psychedelics company Seelos Therapeutics Inc.
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
↗
February 07, 2023
Via
Benzinga
The "Multi-Bagger" Portfolio Continued To Outperform The S&P 500 Last Week
↗
February 06, 2023
Our basket of mostly microcap cannabis, psychedelic and plant-based food stocks was extremely oversold in 2022 but we're watching for them to bounce back in 2023.
Via
Talk Markets
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
↗
February 06, 2023
Via
Benzinga
6 Largest Psychedelic Stocks Down 3% This Week
↗
February 04, 2023
The six largest of the 40 companies researching the treatment of mental illnesses by using psychedelic substances, which constitute our Psychedelic Drug Stocks Index, are now up 13% YTD despite a loss...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 3, 2023
↗
February 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
↗
February 02, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
↗
February 01, 2023
Via
Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
↗
January 31, 2023
Via
Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
↗
January 30, 2023
Via
Benzinga
The "Multi-Bagger" Portfolio Update: Week Ending January 27
↗
January 29, 2023
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but many of them could possibly bounce back with major returns in 2023. We track the performance of a basket of 10 such...
Via
Talk Markets
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD
↗
January 28, 2023
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results.
Via
Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
January 27, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
↗
January 26, 2023
Via
Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
↗
January 25, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
↗
January 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
↗
January 23, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
